Advertisement

Cost Effectiveness of Colonoscopy, Based on the Appropriateness of an Indication

      Background & Aims

      Determination of the appropriateness of an indication for colonoscopy has been advanced as a means to help rationalize the use of endoscopic resources. However, the efficacy and cost effectiveness of the current guidelines used to select patients for colonoscopy are largely unknown. The goal of this study was to assess the clinical and economic impact of American Society for Gastrointestinal Endoscopy and the European Panel on the appropriateness of Gastrointestinal Endoscopy appropriateness guidelines in selecting patients who are referred for colonoscopy, in relation to colorectal cancer (CRC) detection.

      Methods

      A decision-analysis model was constructed to compare colonoscopy strategies for “appropriate” indications with those for which colonoscopy is deemed “inappropriate” or “generally not indicated.” A 50% cancer upstaging was modeled to simulate cancer progression for patients not referred for colonoscopy. CRC prevalence was estimated using a pooled data analysis based on a systematic review of the literature. Costs of colonoscopy and cancer care were estimated from Medicare reimbursement data. The number of colonoscopies needed to detect one case of cancer and to prevent one cancer-related death and incremental cost-effectiveness ratios (ICER), according to appropriateness categories, were computed in a simulated population of patients that were 60 years of age and referred for colonoscopy.

      Results

      The numbers of appropriate and inappropriate colonoscopies that needed to be performed to detect one patient with cancer were 18 and 93, respectively. Similarly, 115 and 617 colonoscopies would be needed, respectively, to prevent one CRC-related death. The ICER for appropriate and inappropriate colonoscopies, compared with a policy of not referring patients to colonoscopy, was $6154 and $31,807 per life-year gained, respectively. In a sensitivity analysis, only a reduction from the baseline value of 1.1% to 0.2% was associated with an ICER for inappropriate colonoscopy higher than $150,000.

      Conclusions

      Current guidelines regarding the appropriateness of colonoscopy are relatively inefficient in excluding a clinically meaningful CRC risk for patients in whom colonoscopy is generally not indicated, raising serious concerns about their applicability to clinical practice.

      Abbreviations used in this paper:

      ASGE (American Society for Gastrointestinal Endoscopy), CI (confidence interval), CRC (colorectal cancer), EPAGE (European Panel on the appropriateness of Gastrointestinal Endoscopy), ICER (incremental cost-effectiveness ratios), SEER (Surveillance, Epidemiology, and End Results)
      To read this article in full you will need to make a payment
      AGA Member Login
      Login with your AGA username and password.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Boyle P.
        • Ferlay J.
        Cancer incidence and mortality in Europe, 2004.
        Ann Oncol. 2005; 16: 481-488
        • Jemal A.
        • Siegel R.
        • Ward E.
        • et al.
        Cancer statistics, 2007.
        CA Cancer J Clin. 2007; 57: 30-42
        • Winawer S.J.
        • Stewart E.T.
        • Zauber A.G.
        • et al.
        A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy.
        N Engl J Med. 2000; 342: 1766-1772
        • Winawer S.J.
        • Zauber A.G.
        • Ho M.N.
        • et al.
        Prevention of colorectal cancer by colonoscopic polypectomy.
        N Engl J Med. 1993; 329: 1977-1981
        • Pignone M.
        • Saha S.
        • Hoerger T.
        • et al.
        Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force.
        Ann Intern Med. 2002; 137: 96-104
        • Hassan C.
        • Laghi A.
        • Pickhardt P.J.
        • et al.
        Projected impact of colorectal cancer screening with CT colonography on current radiological capacity in Europe.
        Aliment Pharmacol Ther. 2008; 27: 366-374
        • Andriulli A.
        • Annese V.
        • Terruzzi V.
        • et al.
        ”Appropriateness” or “prioritization” for GI endoscopic procedures?.
        Gastrointest Endosc. 2006; 63: 1034-1036
        • American Society for Gastrointestinal Endoscopy
        Appropriate use of gastrointestinal endoscopy.
        Gastrointest Endosc. 2000; 52: 831-837
        • Froehlich F.
        • Pache I.
        • Burnand B.
        • et al.
        Performance of panel-based criteria to evaluate the appropriateness of colonoscopy: a prospective study.
        Gastrointest Endosc. 1998; 48: 128-136
        • Beinfeld M.T.
        • Wittenberg E.
        • Gazelle G.S.
        Cost-effectiveness of whole-body CT screening.
        Radiology. 2005; 234: 415-422
        • Marshall D.
        • Simpson K.N.
        • Earle C.C.
        • et al.
        Economic decision analysis model of screening for lung cancer.
        Eur J Cancer. 2001; 37: 1759-1767
        • Mahadevia P.J.
        • Fleisher L.A.
        • Frick K.D.
        • et al.
        Lung cancer screening with helical computed tomography in older adult smokers.
        JAMA. 2003; 289: 313-322
        • Hassan C.
        • Pickhardt P.J.
        • Laghi A.
        • et al.
        CT colonography to screen for colorectal cancer, extracolonic cancer, and aortic aneurysm: model simulation with cost-effectiveness analysis.
        Arch Intern Med. 2008; 168: 696-705
        • Seematter-Bagnoud L.
        • Vader J.P.
        • Wietlisbach V.
        • et al.
        Overuse and underuse of diagnostic upper gastrointestinal endoscopy in various clinical settings.
        Int J Qual Health Care. 1999; 11: 301-308
        • Tengs T.O.
        • Wallace A.
        One thousand health-related quality-of-life estimates.
        Med Care. 2000; 38: 583-637
        • U.S. Department of Labor
        Bureau of Labor Statistics.
        (Accessed: November 12, 2007)
        • Lieberman D.A.
        Cost-effectiveness model for colon cancer screening.
        Gastroenterology. 1995; 109: 1781-1790
      1. National compensation survey: occupational wages in the United States, June 2005.
        (Accessed: November 17, 2007)
        • Morini S.
        • Hassan C.
        • Meucci G.
        • et al.
        Diagnostic yield of open access colonoscopy according to appropriateness.
        Gastrointest Endosc. 2001; 54: 175-179
        • Siddique I.
        • Mohan K.
        • Hasan F.
        • et al.
        Appropriateness of indication and diagnostic yield of colonoscopy: first report based on the 2000 guidelines of the American Society for Gastrointestinal Endoscopy.
        World J Gastroenterol. 2005; 11: 7007-7013
        • Burnand B.
        • Harris J.K.
        • Wietlisbach V.
        • et al.
        Use, appropriateness, and diagnostic yield of screening colonoscopy: an international observational study (EPAGE).
        Gastrointest Endosc. 2006; 63: 1018-1026
        • Balaguer F.
        • Llach J.
        • Castells A.
        • et al.
        The European panel on the appropriateness of gastrointestinal endoscopy guidelines colonoscopy in an open-access endoscopy unit: a prospective study.
        Aliment Pharmacol Ther. 2005; 21: 609-613
        • Jabar M.F.
        • Halim M.E.
        • Gul Y.A.
        Appropriateness of colonoscopy in a tertiary referral centre.
        Asian J Surg. 2004; 27: 26-31
        • Bersani G.
        • Rossi A.
        • Ricci G.
        • et al.
        Do ASGE guidelines for the appropriate use of colonoscopy enhance the probability of finding relevant pathologies in an open access service?.
        Dig Liver Dis. 2005; 37: 609-614
        • de Bosset V.
        • Froehlich F.
        • Rey J.P.
        • et al.
        Do explicit appropriateness criteria enhance the diagnostic yield of colonoscopy?.
        Endoscopy. 2002; 34: 360-368
        • Adler A.
        • Roll S.
        • Marowski B.
        • et al.
        Appropriateness of colonoscopy in the era of colorectal cancer screening: a prospective, multicenter study in a private-practice setting (Berlin Colonoscopy Project 1, BECOP 1).
        Dis Colon Rectum. 2007; 50: 1628-1638
        • Grassini M.
        • Verna C.
        • Niola P.
        • et al.
        Appropriateness of colonoscopy: diagnostic yield and safety in guidelines.
        World J Gastroenterol. 2007; 13: 1816-1819
        • Chan T.H.
        • Goh K.L.
        Appropriateness of colonoscopy using the ASGE guidelines: experience in a large Asian hospital.
        Chin J Dig Dis. 2006; 7: 24-32
        • Gonvers J.J.
        • Harris J.K.
        • Wietlisbach V.
        • et al.
        • EPAGE Study Group
        A European view of diagnostic yield and appropriateness of colonoscopy.
        Hepatogastroenterology. 2007; 54: 729-735
        • Rex D.K.
        • Kahi C.J.
        • Levin B.
        • et al.
        Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer.
        Gastroenterology. 2006; 130: 1865-1871
        • Lieberman D.A.
        • Holub J.
        • Eisen G.
        • et al.
        Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States.
        Clin Gastroenterol Hepatol. 2005; 3: 798-805
        • Imperiale T.F.
        • Wagner D.R.
        • Lin C.Y.
        • et al.
        Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings.
        N Engl J Med. 2000; 343: 169-174
        • Stryker S.J.
        • Wolff B.G.
        • Culp C.E.
        • et al.
        Natural history of untreated colonic polyps.
        Gastroenterology. 1987; 93: 1009-1013
      2. http://seer.cancer.gov/faststats/. Available at www.cdc.gov. Accessed November 12, 2007.

        • Frazier A.L.
        • Colditz G.A.
        • Fuchs C.S.
        • et al.
        Cost-effectiveness of screening for colorectal cancer in the general population.
        JAMA. 2000; 284: 1954-1961
        • Pickhardt P.J.
        • Hassan C.
        • Laghi A.
        • et al.
        Cost-effectiveness of colorectal cancer screening with CT colonography: the impact of not reporting diminutive lesions.
        Cancer. 2007; 109: 2213-2221
        • Gyrd-Hansen D.
        • Søgaard J.
        • Kronborg O.
        Analysis of screening data: colorectal cancer.
        Int J Epidemiol. 1997; 26: 1172-1181
        • Arber N.
        • Eagle C.J.
        • Spicak J.
        • et al.
        Celecoxib for the prevention of colorectal adenomatous polyps.
        N Engl J Med. 2006; 355: 885-895

      Linked Article